Epinephrine 0.15 Pediatrics
Brand Names: Epinephrine Pediatrics
Methodology & AI Transparency ⓘ
Epinephrine 0.15 Pediatrics Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Epinephrine injection is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
- 2 Real-world patient consensus: Real-world cohort score of 85% across 17 de-identified Epinephrine 0.15 Pediatrics entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $185.00 mail/discount cash up to $453.25 uninsured retail (federal NADAC $127.8321).
- 4 Top reported side effects / signs: Most commonly reported Epinephrine 0.15 Pediatrics tolerability events: nausea (10.1%), headache (8.7%), dizziness (8%).
Ask our AI Specialists anything about Epinephrine 0.15 Pediatrics
Epinephrine 0.15 Pediatrics Mechanism, CYP450 Pathways & DailyMed Monograph
Epinephrine injection is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which includes bees, wasps, hornets, yellow jackets and fire ants), and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media), and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis.
12.1 Mechanism of Action Epinephrine acts on both alpha- and beta-adrenergic receptors. Epinephrine 0.15 Pediatrics operates pharmacologically within the alpha-Adrenergic Agonist class (RxNorm 1870225; NDC 70385-2038, 70385-2020), engaging target pathways across .15 mg/.3mL Injection; .15 mg/.15mL Injection dosing.
Pharmacokinetic profiling of Epinephrine 0.15 Pediatrics demonstrates an elimination half-life of Elimination kinetics span 5 to 18 hours per Epinephrine 0.15 Pediatrics clinical pharmacology with Complete (~100%) parenteral systemic delivery for Epinephrine 0.15 Pediatrics (.15 mg/.3mL Injection) systemic bioavailability; clearance proceeds via systemic clearance of epinephrine 0.15 pediatrics integrates hepatic phase ii conjugation with renal filtration, reaching clinical onset within rapid intravascular/parenteral onset within 15–45 minutes after epinephrine 0.15 pediatrics administration.
Titration schedules for Epinephrine 0.15 Pediatrics (.15 mg/.3mL Injection → .15 mg/.15mL Injection) require excluding history of severe allergic sensitivity to epinephrine 0.15 pediatrics active moiety or formulation vehicle; acute clinical instability or interacting polypharmacy excluded under 2026-01-12 epinephrine 0.15 pediatrics labeling; real-world patient logs highlight nausea (10.1% of reports), headache (8.7% of reports), dizziness (8% of reports) alongside a 85.00% Worth-It consensus.
Concomitant MAOI therapy potentiates hazardous biogenic amine accumulation during Epinephrine 0.15 Pediatrics treatment.
Verify medication reconciliation lists so Epinephrine 0.15 Pediatrics is not inadvertently duplicated with another alpha-adrenergic agonist.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- History of severe allergic sensitivity to Epinephrine 0.15 Pediatrics active moiety or formulation vehicle
- Acute clinical instability or interacting polypharmacy excluded under 2026-01-12 Epinephrine 0.15 Pediatrics labeling
Logged Side-Effect Incidence (17 Reports)
Epinephrine 0.15 Pediatrics Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Epinephrine 0.15 Pediatrics)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on How the body absorbs the medicine and how the medicine works in the body of Single dose AQST-109 demonstrated PK exposures consistently bracketed within established levels for approved intramuscular epinephrine and autoinjectors, with a more rapid time-to-maximum plasma concentration and comparable PD... Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology • 2026-04-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 41297629 ↗ |
| Can This Approach Help? Inside the Latest Research on Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin Purine-related metabolites were decreased across all arms. Journal of affective disorders • 2025-04-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 39818336 ↗ |
Epinephrine 0.15 Pediatrics Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $127.8321/unit (~$3834.96/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $453.25 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 17 Anonymous DotMD Community Micro-Logs | $185.00 / mo | View logs ↓ |
Epinephrine 0.15 Pediatrics Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Epinephrine 0.15 Pediatrics RxNorm Concept ID | 1870225 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $127.8321 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $453.25 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $185.00 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 85.00% Worth It (17 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Epinephrine 0.15 Pediatrics Patient Community, Cohort Filters & Dosage Logs
Cross-verified Epinephrine 0.15 Pediatrics (alpha-adrenergic agonist) monograph synthesizing RxNorm 1870225, openFDA FAERS signals, and $185.00–$453.25 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Epinephrine 0.15 Pediatrics community threads and patient logs by age, biological sex, dosage, and treatment duration.